Breckenridge set to release Prilosec generic
BOCA RATON, Fla. — Breckenridge Pharmaceutical Inc. has earned Food and Drug Administration approval for omeprazole delayed-release capsules, an antacid, in 10-mg, 20-mg, 40-mg dosages. Breckenridge said its omeprazole product, AB-rated to AstraZeneca’s Prilosec, will be manufactured and supplied by its parent company, Laboratorios Dr. Esteve S.A., based in Barcelona, Spain. Launch plans are under
